SWU eJournals System
metadata only
Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.#275382
- Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology#273312
- Rational design of k-casein peptides to modulate GSK-3B dynamics for Alzheimer's therapy.#123101
- Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome#948442
- Artificial intelligence revolutionizing CNS drug discovery and development.#334803
Record · ID 320931
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive